8 minute read
Apr. 29, 2023

The First Dengue NS3-NS4B Inhibitor to Enter the Clinic

JNJ-1802

oral first-in-class DENV (NS3-NS4B) inhibitor Ph. I for dengue from a DENV-2 phenotypic antiviral screen Nature, March 15, 2023 Janssen, BE + FR

drughunter.com
Drug Hunter Team
Loading...

twitterlinkedinemail

Other molecules you may be interested in